Licensed LNP definition

Licensed LNP means the LNP that is Controlled by CureVac as at the Effective Date pursuant to the LNP Agreement. Any amendment to the LNP Agreement made after the Effective Date shall not adversely affect the rights or increase the obligations of GSK or CureVac under this Agreement.
View Source
Licensed LNP means an LNP that is Controlled by CureVac as at the Effective Date or during the Term pursuant to (i) one or more non-exclusive license agreement(s) between CureVac and [*****], as amended from time to time (including by the Amendment Two to the Development and Option Agreement dated July 10, 2020); or (ii) in case GSK exercises its option under the Option LNP Technology pursuant to Section 2.1.4 and upon the execution of the Option LNP Agreement, a non-exclusive license agreement between CureVac and [*****], as amended from time to time (all such agreement(s), as applicable, "LNP Agreement(s)", and such counterparty, "LNP Provider"). Subject to Section 2.7.1, any amendment to either LNP Agreement made after the Effective Date shall not adversely affect the rights or increase the obligations of GSK or CureVac under this Agreement.
View Source
Licensed LNP means the LNP that is Controlled by CureVac as at the Effective Date pursuant to the LNP Agreements.
View Source

Examples of Licensed LNP in a sentence

  • With respect to a potential step down in royalty rates to account for the expiry of certain Patent Rights, the Parties acknowledge and agree that the CureVac Technology and the LNP Technology licensed hereunder may justify royalty rates for sales of Products in the GSK Territory in different amounts, which rates could be applied separately to Products involving the exercise of CureVac Technology and the Licensed LNP (namely in a ratio of [*****]).

  • With respect to a potential step down in royalty rates to account for the expiry of certain Patent Rights, the Parties acknowledge and agree that the CureVac Licensed IP, Assigned GSK Patents and Licensed LNP IP licensed under this Agreement may justify royalty rates for sales of GSK Products in different amounts, which rates could be applied separately to GSK Products involving the exercise of CureVac Licensed IP, Assigned GSK Patents and Licensed LNP IP.

  • Furthermore, the Parties acknowledge and agree that separate royalty rates may be justified for GSK Products that are Covered by Valid Claims of any Patent Rights comprised in the CureVac Licensed IP, Licensed LNP IP, Licensed Other IP or Assigned GSK Patents and GSK Products that are not Covered by a Valid Claim of any Patent Rights comprised in the CureVac Licensed IP, Licensed LNP IP, Licensed Other IP or Assigned GSK Patents.

  • If GSK has obtained its own LNP Agreement in accordance with clause 2.7, then effective as of the effective date of termination of that LNP Agreement (and, in any event, no later than ##### after the date GSK notifies CureVac under clause 2.7): (a) during the Royalty Term, the royalty reductions set out in clause 4.2.4 in respect of Licensed LNP IP will apply; and (b) after the Royalty Term, clause 4.2.5 will no longer apply.

  • Without prejudice to clause 5.1, all of CureVac’s rights to the CureVac Background Technology, the Licensed LNP IP and the Licensed Other IP relating to the CureVac Programs shall automatically revert back to CureVac at the Effective Date.